Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples

BACKGROUND: According to international guidelines, Human Papillomavirus (HPV) DNA tests represent a valid alternative to Pap Test for primary cervical cancer screening, provided that they guarantee balanced clinical sensitivity and specificity for cervical intraepithelial neoplasia grade 2 or more (...

Descripción completa

Detalles Bibliográficos
Autores principales: Avian, Alice, Clemente, Nicolò, Mauro, Elisabetta, Isidoro, Erica, Di Napoli, Michela, Dudine, Sandra, Del Fabro, Anna, Morini, Stefano, Perin, Tiziana, Giudici, Fabiola, Cammisuli, Tamara, Foschi, Nicola, Mocenigo, Marco, Montrone, Michele, Modena, Chiara, Polenghi, Martina, Puzzi, Luca, Tomaic, Vjekoslav, Valenti, Giulio, Sola, Riccardo, Zanolla, Shivani, Vogrig, Enea, Riva, Elisabetta, Angeletti, Silvia, Ciccozzi, Massimo, Castriciano, Santina, Pachetti, Maria, Petti, Matteo, Centonze, Sandro, Gerin, Daniela, Banks, Lawrence, Marini, Bruna, Canzonieri, Vincenzo, Sopracordevole, Francesco, Zanconati, Fabrizio, Ippodrino, Rudy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115952/
https://www.ncbi.nlm.nih.gov/pubmed/35581584
http://dx.doi.org/10.1186/s12967-022-03383-x

Ejemplares similares

Ejemplares similares